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CASE PRESENTATION
A 39-year-old African woman was admitted to our
Nephrology Department in June 2004 for exploration
of a nephrotic syndrome. Relevant past medical history
included HIV-1-positive infection since 1997. She had been
treated with a combination of nucleoside reverse
transcriptase inhibitors (AZT, 3TC, and abacavir) since
April 2002. One week before admission, her CD4þ
lymphocyte count was 350 mm3 and the RNA viral load
was undetectable.
Findings at admission included blood pressure of 160/
90 mm Hg and peripheral inferior limb edema. Clinical
examination of the heart, abdomen, and nervous system
was normal. Urinary protein excretion was 3.6 g per 24 h,
hematuria 3 104 red blood cells per 1 ml of urine,
albumin 25 g l1, serum creatinine and creatinine
clearance estimated by the Cockroft and Gault formula
were, respectively, 88mmol l1 and 80 ml min1, and
electrolytes were in the normal range, as were C-reactive
protein and serum fibrinogen. Blood count gave
hemoglobin at 10 g per 100 ml, white blood cells
6600 mm3, and platelets 287 109 l1 without
schizocytes. Liver function tests were normal.
Immunoelectrophoresis showed no serum monoclonal
component, serum IgA and IgM were in the normal range,
and IgG was increased to 41.6 g l1 (normal range:
6.9–14 g l1). Serological tests for hepatitis were negative.
Antinuclear antibody (titer of 1:80) was considered
insignificant. Immunological tests were negative for anti-
neutrophil cytoplasm antibodies, and for antibodies
against double-stranded DNA, extractable nuclear
antigens, cardiolipin, and b-2-glycoprotein 1. Blood levels
of complement components C3 and C4 were in the normal
range (1.2 and 0.11 g l1, respectively) (C3 normal range:
0.75–1.4 g l1; C4 normal range: 0.10–0.34 g l1).
CLINICAL DIAGNOSIS
At this stage, the diagnosis of HIV associated nephropathy
(HIVAN), the most common HIV-related chronic glomer-
ulonephritis was highly suspected. Other diagnosis included
the different HIV-associated immune complex glomeru-
lonephritis such as ‘lupus-like’ glomerulonephritis, IgA nephro-
pathy, and membranoproliferative glomerulonephritis.
A first kidney biopsy was performed and showed a typical
focal ‘lupus-like’ glomerulonephritis. Angiotensin-converting
enzyme inhibitor (ramipril 5 mg day1) was started to reduce
proteinuria, and highly active antiretroviral therapy
(HAART) was continued.
CLINICAL FOLLOW-UP
In August 2004, the patient returned to Africa. She stopped
her antiretroviral treatment for 1 month. In November 2004,
she had acute renal failure with serum creatinine of
190 mmol l1 (creatinine clearance 33 ml min1). She was still
in the nephrotic range with a plasma albumin concentration
of 23 g l1 and a 24-h urinary protein loss of 4.5 g. CD4-
positive lymphocyte count was 250 mm3 and RNA viral load
was 4000 copies ml1. A second renal biopsy under optical
microscopy showed that all histological features of lupus-like
glomerulonephritis had disappeared, but there were lesions
typical of HIVAN. Active antiretroviral therapy was resumed,
associated with angiotensin-converting enzyme inhibitor to
reduce urine protein loss, leading to stabilization of renal
function (creatinine 200 mmol l1) and decreased proteinuria
(1.2 g day1). In September 2005, the patient presented with
new acute renal dysfunction (creatinine 508 mmol l1). A
third kidney biopsy showed diffuse lupus-like glomerulone-
phritis. At this time, plasma HIV-1 RNA level was
always undetectable and CD4 cell count was 290 mm3.
Steroid therapy (intravenous methylprednisolone pulses
500 mg day1 on three consecutive days) was combined
with monthly intravenous pulses of cyclophosphamide
(0.5 g m2). This therapeutic regimen failed to improve renal
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function and intermittent hemodialysis was started in
January 2006.
RENAL BIOPSY FINDINGS
The renal first biopsy specimen consisted of renal cortex with
29 glomeruli. Paraffin sections for light microscopy showed
focal endocapillary proliferation and mesangial hypercellu-
larity without collapsing variant of focal segment glomerulo-
sclerosis into 29 glomeruli (Figure 1a). Fibrocellular crescent
formation, hyaline thrombi plugging capillary lumina, and
‘wire loops’ were not observed. Tubulointerstitial changes
included small broads of fibrosis with mild interstitial
inflammatory cell infiltration (o25%). Arterial vessels were
unremarkable and tubule examination did not reveal
microcystic dilatation. Direct immunofluorescence (10 glo-
meruli) showed diffuse ‘full-house’ granular glomerular
capillary and mesangial staining for IgG, IgM, C3, and C1q
with a very weak staining with IgA antibodies (Figure 1b and c).
These pathologic lesions were suggestive of focal lupus-like
glomerulonephritis.
The second renal biopsy (Figure 2) performed in
November 2004 consisted of renal cortex with 18 glomeruli.
Glomerular pathologic findings included focal and segmental
glomerulosclerosis with prominent collapse of the glomerular
tuft into eight glomeruli associated with pronounced
hypertrophy and hyperplasia of visceral epithelial cells, which
formed a cellular corona over the collapsed lobules. Tubules
exhibited atrophy and microcystic dilatation, and an intense
interstitial fibrosis (50% of parenchyma) associated with a
mild inflammatory cellular infiltrate. Immunofluorescence
revealed weak positive staining for IgM, C1q, C3, and IgG in
areas of glomerulosclerosis (data not shown).
The last renal biopsy examination performed in
September 2005 for acute renal failure revealed by light
microscopy diffuse proliferative glomerulonephritis (450%)
a
b c
Figure 1 | First renal biopsy. (a) Light microscopy of the first renal
biopsy (June 2004) showing focal lupus-like glomerulonephritis. The
glomerulus appeared with mesangial and endocapillary
hypercellularity (arrow). Tubules are not dilated and a mild
interstitial infiltrate is present (Masson’s trichrome stains, original
magnification  400). Immunofluorescence study revealed an
intense granular glomerular staining in capillary walls and
mesangium on the first renal biopsy using C1q (b) and IgM
(c) antibodies.
Figure 2 | Light microscopy study on the second renal biopsy
(November 2004) showed typical findings of HIVAN with
collapse of the glomerular tuft and tubular dilatation. Visceral
epithelial cells form a cellular corona over the lobules (arrow).
Reactive blood mononuclear cells were found in the interstitium
(Masson’s trichrome stains, original magnification  400).
Figure 3 | Light microscopy of the third renal biopsy
(September 2005) revealed diffuse proliferative lupus-like
glomerulonephritis with segmental cellular crescents observed
in more than 50% of glomeruli (arrow). Mild interstitial infiltrate
was associated with glomerular lesions. (Masson’s trichrome stains,
original magnification  400).
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with extracapillary cell proliferation and cellular crescents
involving 50% of glomeruli (4/8) with mild interstitial
infiltrate (Figure 3). Other glomeruli presented diffuse
endocapillary proliferative changes with increased mesangial
and intracapillary matrix. Interstitial fibrosis and tubular
atrophy were also present. Immunofluorescence study (seven
glomeruli) showed immunoglobulin (IgM and IgG) and
complement (C3 and C1q) granular staining in the
glomerular capillary walls and in mesangial areas (data not
shown).
QUANTIFICATION OF HIV-1 PROVIRAL DNA IN KIDNEY
BIOPSIES
Renal tissue of each biopsy was analyzed for the presence of
HIV-1 proviral DNA. Total cell DNA was extracted from the
kidney biopsy by adsorption on silica membranes (Qiagen,
Hilden, Germany). HIV-1 proviral DNA was quantified in
duplicate by real-time PCR. TaqMan Exogenous Internal
Positive Control (IPC Kit; AB Applied Biosystems, Foster
City, CA, USA), a preoptimized internal control, was added
to each sample to allow detection of PCR inhibitors. The
amplification was performed and analyzed with an ABI Prism
7000 Sequence Detector System (AB Applied Biosystems). To
normalize sample-to-sample variations in terms of cell count
and yield of DNA extraction, we determined the number of
cells extracted by quantifying the number of copies of
albumin gene in 10 ml of extracted DNA. The PCR primers
for HIV-1 DNA and albumin gene quantifications have been
described elsewhere.1,2
Results were expressed as HIV-1 DNA copies per 1.5 105
cells with a PCR limit of detection of five HIV-1 DNA copies.
The difference was not statistically significant between the
focal lupus-like glomerulonephritis biopsy and HIVAN
biopsy (proviral DNA 36 copies and 15 copies per 1.5 105
cells, respectively), whereas HIV-1 proviral DNA significantly
increased in kidney biopsy specimens of diffuse proliferative
lupus-like glomerulonephritis (125 copies per 1.5 105 cells)
(Table 1).
DISCUSSION
We report the successive occurrence of three distinct
HIV-associated glomerular lesions in the same patient during
a 15-month follow-up. These histological lesions included
HIVAN, the most common HIV-related nephropathy, and
lupus-like glomerulonephritis alternatively revealed by focal
endocapillary proliferation and then diffuse proliferative
glomerulonephritis leading to end-stage renal failure.
HIV-related glomerular disease
HIV-related glomerular disease included a large variety of
pathological entities. The first glomerulonephritis presented
by this patient was lupus-like. This lesion seems to be
increasingly recognized, mainly in European HIV-infected
populations.3,4 Lupus-like glomerulonephritis is character-
ized by the presence of immunoglobulins (IgA, IgM, and
IgG) and complement deposits (C3 and C1q) within the
mesangium on immunofluorescence in the absence of
serologic evidence of systemic lupus erythematosus.3,5 Both
diffuse and focal forms of proliferative glomerulonephritis
have been described in the context of lupus-like glomerulo-
nephritis.3 Little is currently known about clinical features
and treatment of lupus-like glomerulonephritis. Hass et al.3
has recently report clinicopathologic study of 14 cases of
HIV-associated immune complex glomerulonephritis. Most
of them presented with nephritic syndrome (10/14) and
had serum creatinine 43 mg per 100 ml (9/14). Ten of the
fourteen patients developed end-stage renal disease within 1
year of the biopsy. Five of these patients were treated with
HAART and only two showed an improvement in renal
function. Such results are in agreement with results from a
multicenter study that failed to show a significant effect of
antiretroviral therapy on renal survival of patients with a
variety of glomerular lesions other than HIVAN.6 In our
report, HAART also failed to preclude the occurrence
of lupus-like glomerulonephritis. While efficiency of
corticosteroids has been reported in HIVAN, disappointing
results were observed in the treatment of lupus-like
Table 1 | Laboratory, immunological, and virological monitoring during renal disease
Normal range
Focal lupus-like
proliferative
glomerulonephritis,
June 2004
HIVAN,
November 2004
Diffuse lupus-like
proliferative glomerulonephritis,
September 2005
Creatinine (mmol l1) 60–130 88 190 508
Creatinine clearance (ml min1) 80 33 12
Urinary protein (g day1) o0.3 3.6 4.5 1.9
Albumin level (g l1) 32–50 25 23 27
Hematuria (ml1) o104 3 104 2.5 104 5 105
Hemoglobin (g per 100 ml) 13–17.7 10 9.7 9.2
White blood cells (mm3) 4000–10 000 6600 5800 6200
CD4 count (cells mm3) 745–1050 350 250 290
Plasma RNA viral load
(copies ml1)
o50 4000 o50
Proviral DNA in renal tissue
(copies per 1.5 105 cells)
36 15 125
HIVAN, HIV-associated nephropathy.
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glomerulonephritis.3 In our case, the use of corticosteroids
for the treatment of the diffuse proliferative glomerulone-
phritis did not prevent the occurrence of end-stage renal
disease.
Others causes of HIV-related chronic glomerulopathy also
include classic HIV-associated nephropathy with focal
segment glomerulosclerosis, so-called HIVAN, the thrombo-
tic microangiopathy, and IgA nephropathy. Each syndrome
has its own clinical presentation, epidemiologic characteris-
tics, and therapy. Main characteristics of the different entities
are depicted in Table 2. Among causes of glomerulonephritis,
HIVAN is the most common HIV-associated nephropathies.
This syndrome has been reported in all stages of HIV
infection, including during acute seroconversion. Others
glomerulonephritis are mainly reported during the course of
chronic infection although lupus-like glomerulonephritis has
been reported once during seroconversion.7
Pathogenesis hypothesis
Whether clinicopathological presentation occurs in one or
another form of chronic or acute nephropathy is still
misunderstood. However, recent findings on pathogenesis
of HIV-related nephropathy may help the clinician to
understand such heterogeneous presentation. Here, we will
discuss only the potential differential mechanisms involved in
HIVAN and lupus-like glomerulonephritis.
The pathogenesis of lupus-like nephropathy remains
unclear. Immunoglobulins may bind circulating HIV anti-
gens, resulting in formations of circulating immune com-
plexes, but in situ immune complex formation might be
initiated by the presence of HIV genome in renal tissue.8
Such circulating immune complexes are capable of forming
during all stages of HIV infection.7,8 In our case, lupus-like
glomerulonephritis occurred while plasma RNA viral load
was low (o50 copies ml1) during both focal and prolif-
erative glomerulonephritis, while proviral DNA copies in
renal tissue were respectively two- and eightfold higher
compared with the proviral DNA load observed during
HIVAN. These results strengthen the in situ circulating
immune complex formation hypothesis. Six months after the
first episode of lupus-like nephropathy, the histological
lesions turned into classical HIV-associated focal segment
glomerulosclerosis in the context of increased plasma RNA
viral load (from o50 to 4000 copies ml1). In contrast with
HIV-associated immune complex deposits, pathogenesis of
HIVAN has been extensively studied. Both experimental data
from HIV transgenic mouse models and human renal
biopsies suggest that HIV infection of renal tubular cells
and podocytes is directly responsible for the renal lesions
observed.9 In 2000, Bruggeman et al.10 detected HIV-1 RNA
by in situ hybridization in renal tubular cell epithelial cells,
podocytes, and parietal epithelial in patients suffering from
Table 2 | HIV-related glomerular disease
HIVAN Lupus-like glomerulonephritis IgA nephropathy
Thrombotic
microangiopathy
Stage of HIV infection Chronic HIV infection,
acute seroconversion
Chronic HIV infection,
acute seroconversion
Chronic HIV infection Chronic HIV infection
Risk factors All risk groups for infection,
mainly in African and intravenous
drug use
All risk groups for infection,
mainly in Caucasian patients
Caucasian patients Male predominance (80%),
mean age of onset 35 years,
more common in Caucasian
patients
Renal presentation Nephrotic syndrome,
±hypertension,
±hematuria,
±renal insufficiency
Nephrotic syndrome,
±hematuria,
acute renal failure
Hematuria and
proteinuria
Renal insufficiency,
hemolytic anemia,
platelet consumption
Renal pathology Focal segmental
glomerulosclerosis;
collapsing nephropathy with
marked podocyte hypertrophy
and hyperplasia; microcystic
dilatation of tubules; T
lymphocytic interstitial infiltrates;
endothelial tubuloreticular
inclusion
Endocapillary proliferative
glomerulonephritis, ±crescents
formation; B lymphocytic
interstitial infiltrates;
subendothelial deposits (wire
loops);
hyaline thrombi plugging
capillary lumina
Immunoglobulin A
nephropathy
Thrombi in glomerular
capillaries, in small arterial,
and arterioles vessels;
mesangiolysis; endothelial
cell edema
Immunofluorescence
study
IgM, C3 in areas of
glomerulosclerosis, and in the
mesangium
Full-house pattern of Ig
(IgG, IgM, and IgA) and
complement (C3 and C1q) in
the mesangium, intracapillary
region, and subepithelial space
Diffuse mesangial
IgA deposits
Fibrin and fibrinogen in
arterioles;
fibrinogen, Ig (IgG, IgM, and
IgA), and complement
(C3, C4, and C1q) in
glomeruli
Treatment HAART: may improve renal
survival; steroids: may improve
renal function and reduce
proteinuria; ACE inhibitor may
improve renal survival
Not available Not available tPlasma infusion,
plasmapheresis, HAART
ACE, angiotensin-converting enzyme; HAART, highly active antiretroviral therapy; HIVAN, HIV-associated nephropathy.
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HIVAN. Interestingly, HIV-1 mRNA persists in the renal
epithelium in spite of renal function and histological
improvement concomitant with undetectable plasma viral
RNA after initiation of HAART in a patient with HIVAN.11
Nef protein seems to play a crucial role in the pathogenesis of
HIVAN. In transgenic mice, expression of Nef is necessary
and sufficient to induce renal disease similar to HIVAN.12
Moreover, He et al.12 showed that Nef induces specific
signaling pathways in podocytes of patients with HIVAN. In
our case, we could hypothesize that HIV-1 replication in the
plasma was associated with synthesis of viral proteins such as
Nef, which could induce secondary podocyte proliferation
and dedifferentiation.13 The third histological change (from
HIVAN into diffuse proliferative glomerulonephritis) was
associated with both decreased plasma RNA viral load (from
4000 to o50 copies ml1) and an eightfold increase in
proviral DNA load in renal tissue. This suggests that, while
HIVAN lesions are directly related to plasma viral load
(‘direct pathogenic effect’), in most cases, lupus-like glomerulo-
nephritis is more sensitive to local DNA load, suggesting an
immune process.
CONCLUSION
We report here the results of HIV viral load quantification in
renal biopsies from a patient with lupus-like glomerulone-
phritis. This confirms the pathological heterogeneity of HIV-
associated glomerular lesions and highlights the potential
interest of repeat histological investigations in such patients.
The sequential monitoring of HIV RNA or proviral
DNA expression in both plasma and kidney demonstrates
the potential influence of local and systemic viral load on
the clinical and histological expression of HIV-related
nephropathy.
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